BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 190276)

  • 1. Inhibition of G2 phase in unsynchronized HELA cells: synergism between adenosine 3':5'-monophosphate analogues and phosphodiesterase inhibitors.
    Kurz JB; Friedman DL
    J Cyclic Nucleotide Res; 1976; 2(6):405-15. PubMed ID: 190276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cyclic nucleotides in the cell cycle.
    Friedman DL; Johnson RA; Zeilig CE
    Adv Cyclic Nucleotide Res; 1976; 7():69-114. PubMed ID: 188318
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of four methylxanthine compounds and norepinephrine on cardiac phosphorylase activation and cardiac contractility.
    McNeill JH; Brenner MJ; Muschek LD
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():261-73. PubMed ID: 4377599
    [No Abstract]   [Full Text] [Related]  

  • 4. Augmentation of postconfluence growth arrest of 10T1/2 fibroblasts by endogenous cyclic adenosine 3':5'-monophosphate.
    Matsukawa T; Bertram JS
    Cancer Res; 1988 Apr; 48(7):1874-81. PubMed ID: 2832054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
    Miot F; Erneux C; Wells JN; Dumont JE
    Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue selective inhibition of cyclic nucleotide phosphodiesterase by denbufylline.
    Wilke R; Arch JR; Nicholson CD
    Arzneimittelforschung; 1989 Jun; 39(6):665-7. PubMed ID: 2476135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo inhibitory effects of propentofylline on cyclic AMP phosphodiesterase activity.
    Nagata K; Ogawa T; Omosu M; Fujimoto K; Hayashi S
    Arzneimittelforschung; 1985; 35(7):1034-6. PubMed ID: 2996562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirements for and kinetics of growth arrest of neoplastic cells by confluent 10T1/2 fibroblasts induced by a specific inhibitor of cyclic adenosine 3':5'-phosphodiesterase.
    Bertram JS; Faletto MB
    Cancer Res; 1985 May; 45(5):1946-52. PubMed ID: 2985240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of adenosine 3',5'-monophosphate phosphodiesterase by nicotinamide and its homologues in vitro.
    Shimoyama M; Kawai M; Nasu S; Shioji K; Hoshi Y
    Physiol Chem Phys; 1975; 7(2):125-32. PubMed ID: 239431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of conidia aggregation in Aspergillus niger by cyclic AMP and 5'-GMP.
    Wold WS; Suzuki I
    Biochem Biophys Res Commun; 1973 Dec; 55(3):824-30. PubMed ID: 4357432
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of fibroblast cyclic AMP escape and cyclic nucleotide phosphodiesterase activities by xanthines.
    Nemecek GM; Wells JN; Butcher RW
    Mol Pharmacol; 1980 Jul; 18(1):57-64. PubMed ID: 6251359
    [No Abstract]   [Full Text] [Related]  

  • 13. Circadian periodicity a neurospora: alteration by inhibitors of cyclic AMP phosphodiesterase.
    Feldman JF
    Science; 1975 Nov; 190(4216):789-90. PubMed ID: 173018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase inhibitors as tools in cyclic nucleotide research: a precautionary comment.
    Wells JN; Kramer GL
    Mol Cell Endocrinol; 1981 Jul; 23(1):1-9. PubMed ID: 6167475
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
    Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
    Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
    Zhou L; Thompson WJ; Potter DE
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1745-52. PubMed ID: 10393044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts.
    Marko D; Romanakis K; Zankl H; Fürstenberger G; Steinbauer B; Eisenbrand G
    Cell Biochem Biophys; 1998; 28(2-3):75-101. PubMed ID: 9515161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.
    Rybalkin SD; Bornfeldt KE
    Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of cyclic nucleotides on growth activity of V79-1A cells.
    Kovár J
    Folia Biol (Praha); 1981; 27(5):346-53. PubMed ID: 6271603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of hepatoma cell growth by analogs of adenosine and cyclic AMP and the influence of enzymes in mammalian sera.
    Hargrove JL; Granner DK
    J Cell Physiol; 1982 Jun; 111(3):232-8. PubMed ID: 6124549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.